The original ALCOA acronym (Attributable, Legible, Contemporaneous, Original, Accurate) came from FDA guidance on data integrity in regulated manufacturing. The "+" additions, Complete, Consistent, Enduring, Available, extended it to cover the full data lifecycle, not just the moment a record is created.

In practice, a batch record review checks every entry against these principles: is it clear who recorded each data point (attributable), was it recorded at the time the work happened, not backfilled later (contemporaneous), and does the full record hang together without gaps or contradictions (complete and consistent).

Frequently Asked Questions

What does "contemporaneous" mean in this context?

It means data was recorded at the time the activity actually happened, not reconstructed or filled in from memory afterward. A timestamp mismatch between when work occurred and when it was logged is exactly what this principle is designed to catch.

Why does pharmaceutical manufacturing care so much about data integrity specifically?

Because a batch record is the evidence that a specific drug product was made correctly and safely. If the underlying data can't be trusted, no one, including the regulator, can trust the product it describes, which is why ALCOA+ violations are treated so seriously in FDA and EU GMP inspections.

How does an AI agent apply ALCOA+ when reviewing a batch record?

It checks completeness (are all required fields filled in), reconciles yield calculations, flags timestamp inconsistencies, and identifies deviations or out-of-specification results, producing a structured review report rather than a pass/fail with no detail.

Is ALCOA+ only relevant to paper records?

No, it applies equally to electronic batch records and digital systems (often discussed alongside 21 CFR Part 11 for electronic records and signatures), and in some ways matters even more there, since electronic data can be altered in ways that are harder to detect without proper audit trails.